imig international mesothelioma interest group conference boston 2012 research treatments

The Meso Foundation Congratulates Dr. Hassan for Prestigious Award

The Mesothelioma Applied Research Foundation congratulates Dr. Raffit Hassan of the National Cancer Institute (NCI) on receiving the prestigious Wagner Award at this year’s International Mesothelioma Interest Group’s (iMig) meeting.
Raffit Hassan, MD, is an Investigator and Chief of the Solid Tumor Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute. Dr. […]


UPDATES FROM IMIG: Part 2, Thursday, September 13, 2012

In a talk concerning adjuvant radiation following EPP, it was stated that radiation oncologists who are inexperienced may not give as high a dose or may shy away from difficult areas.  It was felt to be important based upon lower local failure in centers with expertise in radiation oncology.  Concern was expressed about patients having […]


UPDATES FROM IMIG: Part 1 – Thursday, September 13

Dr. David Sugarbaker spoke about the effectiveness of surgery and some of the adjuvant therapies that can be used to clean up the surgical site or to combat recurrent disease. We heard about biologics, photodynamic therapy, and there will be sessions later today on intracavitary heated chemotherapy during surgery, and then more on staging, imaging, […]


Intro to iMig: iMig and the Meso Foundation

What is iMig?
In the next week and a half, you will be hearing a lot about the iMig meeting. This may leave you with a few questions, first one of which probably being “what is iMig?”
The International Mesothelioma Interest Group (iMig) is an independent international group of scientists and clinicians working to understand, cure and […]